Moschoutis P, Labib A, Le Quintrec Y, Fenton J, Mathieu G
Service de Gastroentérologie et de Nutrition, Hôpital Rothschild, Paris.
Ann Gastroenterol Hepatol (Paris). 1992 Jan-Feb;28(1):1-6.
A prospective study was made of 80 patients with a history of gynecological malignancy, and who had received radiotherapy 2 to 5 years previously in the same centre, with the aim of determining the incidence of lesions of the small intestine after pelvic radiotherapy. Various moderate gastrointestinal symptoms were seen in 33 patients and incapacitating diarrhea in 2. Thirty-seven patients underwent gastrointestinal investigations. The great majority had a good nutritional status and normal laboratory results. Fecal losses on a normal oral diet and alpha-1-antitrypsin clearance were most often normal (3 cases of steatorrhea, 8 of creatorrhea). Small bowel barium studies revealed minor abnormalities of folds in 5 cases. There was no correlation between clinical symptomatology and the existence of laboratory and radiological abnormalities. This study shows the usual good tolerance of pelvic radiotherapy by the small intestine, at least in the mid-term. Routine investigations seeking sub-clinical intestinal lesions do not appear to be justified in patients who have undergone pelvic radiotherapy.
对80例有妇科恶性肿瘤病史且在同一中心于2至5年前接受过放疗的患者进行了一项前瞻性研究,目的是确定盆腔放疗后小肠病变的发生率。33例患者出现各种中度胃肠道症状,2例出现失能性腹泻。37例患者接受了胃肠道检查。绝大多数患者营养状况良好,实验室检查结果正常。正常口服饮食时的粪便损失和α-1抗胰蛋白酶清除率大多正常(3例脂肪泻,8例氮泻)。小肠钡剂造影显示5例褶皱有轻微异常。临床症状与实验室及放射学异常的存在之间无相关性。本研究表明,至少在中期,小肠对盆腔放疗通常耐受性良好。对于接受过盆腔放疗的患者,寻求亚临床肠道病变的常规检查似乎没有必要。